Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Saved in:
| Title: | Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240). |
|---|---|
| Authors: | Penson, Richard T (AUTHOR), Huang, Helen Q (AUTHOR), Wenzel, Lari B (AUTHOR), Monk, Bradley J (AUTHOR), Stockman, Sharon (AUTHOR), Long 3rd, Harry J (AUTHOR), Ramondetta, Lois M (AUTHOR), Landrum, Lisa M (AUTHOR), Oaknin, Ana (AUTHOR), Reid, Thomas J A (AUTHOR), Leitao, Mario M (AUTHOR), Method, Michael (AUTHOR), Michael, Helen (AUTHOR), Tewari, Krishnansu S (AUTHOR), Long, Harry J 3rd1 (AUTHOR) |
| Source: | Lancet Oncology. Mar2015, Vol. 16 Issue 3, p301-311. 11p. |
| Database: | Academic Search Ultimate |
| ISSN: | 14702045 |
|---|---|
| DOI: | 10.1016/S1470-2045(15)70004-5 |
